BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba
The convergence of life sciences with neurosciences, nanotechnology, data management, and engineering has caused a technological diversification of the biotechnology, pharmaceutical, and medical technology industries, including the phenomenon of digital transformation, which has given rise to the so...
Gespeichert in:
| Veröffentlicht in: | Journal of interferon & cytokine research 2023-12, Vol.43 (12), p.571-580 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 580 |
|---|---|
| container_issue | 12 |
| container_start_page | 571 |
| container_title | Journal of interferon & cytokine research |
| container_volume | 43 |
| creator | Bello-Rivero, Iraldo Crombet-Ramos, Tania Mesa-Pardillo, Circe Morera-Díaz, Yanelys Mazorra-Herrera, Zaima Garcia-Rivera, Dagmar Nodarse-Cuní, Hugo Hernández-Bernal, Francisco Muzio-Gonzalez, Verena Aguilera-Barreto, Ana Vazquez-Blomquist, Dania Domínguez-Horta, Maria Del Carmen Guillen-Nieto, Gerardo |
| description | The convergence of life sciences with neurosciences, nanotechnology, data management, and engineering has caused a technological diversification of the biotechnology, pharmaceutical, and medical technology industries, including the phenomenon of digital transformation, which has given rise to the so-called Fourth Industrial Revolution (Industry 4.0). Confronting the COVID-19 pandemic revealed the outstanding response capacity of the scientific community and the biopharmaceutical industry, based on a multidisciplinary and interinstitutional approach that has achieved an unprecedented integration in the history of biomedical science. Cuba, a small country, with scarce material resources, has had remarkable success in controlling the disease, which also highlights the impact of social factors. This report presents a summary of the most relevant presentations of selected topics during the scientific meeting, “BioHabana 2022: Cancer Immunotherapy and the COVID-19 Pandemic,” which was held in Havana Cuba in April 2022. |
| doi_str_mv | 10.1089/jir.2023.0141 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2898312293</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2898312293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-5cff0c4867481ae9e9205d2756fdbb6e02a0c8b82c11b9a90f708ea99e57b6453</originalsourceid><addsrcrecordid>eNqFkD1PHDEQhq0IFD6SMm3kkmaPsffLTgebACchgUSS1hr7ZonRrfewvUj8e_ZyQEs1r0bPvCM9jH0TsBCg9OmDjwsJslyAqMQndijqui3aqqn35gytLrSG9oAdpfQAAI2S-jM7KBVUc9KHzJz78QotBuRzi_zBbyM9Ucj-iTiGFV8OwxTG_I8ibmjK3vG7HDHTvafEz-7Rh5R5d_N3-bMQ-v9Fh8FR5D7wbrL4he33uE709XUesz8Xv353V8X1zeWyO7sunNRlLmrX9-Aq1bSVEkiatIR6Jdu66VfWNgQSwSmrpBPCatTQt6AItaa6tU1Vl8fsZNe7iePjRCmbwSdH6zUGGqdkpNKqFHJ-NqPFDnVxTClSbzbRDxifjQCzdWpmp2br1Gydzvz31-rJDrR6p98kzkC5A7ZrDGHtyVLMH9S-AMbCgZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2898312293</pqid></control><display><type>article</type><title>BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bello-Rivero, Iraldo ; Crombet-Ramos, Tania ; Mesa-Pardillo, Circe ; Morera-Díaz, Yanelys ; Mazorra-Herrera, Zaima ; Garcia-Rivera, Dagmar ; Nodarse-Cuní, Hugo ; Hernández-Bernal, Francisco ; Muzio-Gonzalez, Verena ; Aguilera-Barreto, Ana ; Vazquez-Blomquist, Dania ; Domínguez-Horta, Maria Del Carmen ; Guillen-Nieto, Gerardo</creator><creatorcontrib>Bello-Rivero, Iraldo ; Crombet-Ramos, Tania ; Mesa-Pardillo, Circe ; Morera-Díaz, Yanelys ; Mazorra-Herrera, Zaima ; Garcia-Rivera, Dagmar ; Nodarse-Cuní, Hugo ; Hernández-Bernal, Francisco ; Muzio-Gonzalez, Verena ; Aguilera-Barreto, Ana ; Vazquez-Blomquist, Dania ; Domínguez-Horta, Maria Del Carmen ; Guillen-Nieto, Gerardo</creatorcontrib><description>The convergence of life sciences with neurosciences, nanotechnology, data management, and engineering has caused a technological diversification of the biotechnology, pharmaceutical, and medical technology industries, including the phenomenon of digital transformation, which has given rise to the so-called Fourth Industrial Revolution (Industry 4.0). Confronting the COVID-19 pandemic revealed the outstanding response capacity of the scientific community and the biopharmaceutical industry, based on a multidisciplinary and interinstitutional approach that has achieved an unprecedented integration in the history of biomedical science. Cuba, a small country, with scarce material resources, has had remarkable success in controlling the disease, which also highlights the impact of social factors. This report presents a summary of the most relevant presentations of selected topics during the scientific meeting, “BioHabana 2022: Cancer Immunotherapy and the COVID-19 Pandemic,” which was held in Havana Cuba in April 2022.</description><identifier>ISSN: 1079-9907</identifier><identifier>ISSN: 1557-7465</identifier><identifier>EISSN: 1557-7465</identifier><identifier>DOI: 10.1089/jir.2023.0141</identifier><identifier>PMID: 38048299</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc., publishers</publisher><subject>COVID-19 ; Cuba ; Humans ; Immunotherapy ; Meeting Report ; Neoplasms - prevention & control ; Pandemics - prevention & control</subject><ispartof>Journal of interferon & cytokine research, 2023-12, Vol.43 (12), p.571-580</ispartof><rights>2023, Mary Ann Liebert, Inc., publishers</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c293t-5cff0c4867481ae9e9205d2756fdbb6e02a0c8b82c11b9a90f708ea99e57b6453</cites><orcidid>0000-0001-5011-2850</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38048299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bello-Rivero, Iraldo</creatorcontrib><creatorcontrib>Crombet-Ramos, Tania</creatorcontrib><creatorcontrib>Mesa-Pardillo, Circe</creatorcontrib><creatorcontrib>Morera-Díaz, Yanelys</creatorcontrib><creatorcontrib>Mazorra-Herrera, Zaima</creatorcontrib><creatorcontrib>Garcia-Rivera, Dagmar</creatorcontrib><creatorcontrib>Nodarse-Cuní, Hugo</creatorcontrib><creatorcontrib>Hernández-Bernal, Francisco</creatorcontrib><creatorcontrib>Muzio-Gonzalez, Verena</creatorcontrib><creatorcontrib>Aguilera-Barreto, Ana</creatorcontrib><creatorcontrib>Vazquez-Blomquist, Dania</creatorcontrib><creatorcontrib>Domínguez-Horta, Maria Del Carmen</creatorcontrib><creatorcontrib>Guillen-Nieto, Gerardo</creatorcontrib><title>BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba</title><title>Journal of interferon & cytokine research</title><addtitle>J Interferon Cytokine Res</addtitle><description>The convergence of life sciences with neurosciences, nanotechnology, data management, and engineering has caused a technological diversification of the biotechnology, pharmaceutical, and medical technology industries, including the phenomenon of digital transformation, which has given rise to the so-called Fourth Industrial Revolution (Industry 4.0). Confronting the COVID-19 pandemic revealed the outstanding response capacity of the scientific community and the biopharmaceutical industry, based on a multidisciplinary and interinstitutional approach that has achieved an unprecedented integration in the history of biomedical science. Cuba, a small country, with scarce material resources, has had remarkable success in controlling the disease, which also highlights the impact of social factors. This report presents a summary of the most relevant presentations of selected topics during the scientific meeting, “BioHabana 2022: Cancer Immunotherapy and the COVID-19 Pandemic,” which was held in Havana Cuba in April 2022.</description><subject>COVID-19</subject><subject>Cuba</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Meeting Report</subject><subject>Neoplasms - prevention & control</subject><subject>Pandemics - prevention & control</subject><issn>1079-9907</issn><issn>1557-7465</issn><issn>1557-7465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PHDEQhq0IFD6SMm3kkmaPsffLTgebACchgUSS1hr7ZonRrfewvUj8e_ZyQEs1r0bPvCM9jH0TsBCg9OmDjwsJslyAqMQndijqui3aqqn35gytLrSG9oAdpfQAAI2S-jM7KBVUc9KHzJz78QotBuRzi_zBbyM9Ucj-iTiGFV8OwxTG_I8ibmjK3vG7HDHTvafEz-7Rh5R5d_N3-bMQ-v9Fh8FR5D7wbrL4he33uE709XUesz8Xv353V8X1zeWyO7sunNRlLmrX9-Aq1bSVEkiatIR6Jdu66VfWNgQSwSmrpBPCatTQt6AItaa6tU1Vl8fsZNe7iePjRCmbwSdH6zUGGqdkpNKqFHJ-NqPFDnVxTClSbzbRDxifjQCzdWpmp2br1Gydzvz31-rJDrR6p98kzkC5A7ZrDGHtyVLMH9S-AMbCgZs</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Bello-Rivero, Iraldo</creator><creator>Crombet-Ramos, Tania</creator><creator>Mesa-Pardillo, Circe</creator><creator>Morera-Díaz, Yanelys</creator><creator>Mazorra-Herrera, Zaima</creator><creator>Garcia-Rivera, Dagmar</creator><creator>Nodarse-Cuní, Hugo</creator><creator>Hernández-Bernal, Francisco</creator><creator>Muzio-Gonzalez, Verena</creator><creator>Aguilera-Barreto, Ana</creator><creator>Vazquez-Blomquist, Dania</creator><creator>Domínguez-Horta, Maria Del Carmen</creator><creator>Guillen-Nieto, Gerardo</creator><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5011-2850</orcidid></search><sort><creationdate>20231201</creationdate><title>BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba</title><author>Bello-Rivero, Iraldo ; Crombet-Ramos, Tania ; Mesa-Pardillo, Circe ; Morera-Díaz, Yanelys ; Mazorra-Herrera, Zaima ; Garcia-Rivera, Dagmar ; Nodarse-Cuní, Hugo ; Hernández-Bernal, Francisco ; Muzio-Gonzalez, Verena ; Aguilera-Barreto, Ana ; Vazquez-Blomquist, Dania ; Domínguez-Horta, Maria Del Carmen ; Guillen-Nieto, Gerardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-5cff0c4867481ae9e9205d2756fdbb6e02a0c8b82c11b9a90f708ea99e57b6453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19</topic><topic>Cuba</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Meeting Report</topic><topic>Neoplasms - prevention & control</topic><topic>Pandemics - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bello-Rivero, Iraldo</creatorcontrib><creatorcontrib>Crombet-Ramos, Tania</creatorcontrib><creatorcontrib>Mesa-Pardillo, Circe</creatorcontrib><creatorcontrib>Morera-Díaz, Yanelys</creatorcontrib><creatorcontrib>Mazorra-Herrera, Zaima</creatorcontrib><creatorcontrib>Garcia-Rivera, Dagmar</creatorcontrib><creatorcontrib>Nodarse-Cuní, Hugo</creatorcontrib><creatorcontrib>Hernández-Bernal, Francisco</creatorcontrib><creatorcontrib>Muzio-Gonzalez, Verena</creatorcontrib><creatorcontrib>Aguilera-Barreto, Ana</creatorcontrib><creatorcontrib>Vazquez-Blomquist, Dania</creatorcontrib><creatorcontrib>Domínguez-Horta, Maria Del Carmen</creatorcontrib><creatorcontrib>Guillen-Nieto, Gerardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of interferon & cytokine research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bello-Rivero, Iraldo</au><au>Crombet-Ramos, Tania</au><au>Mesa-Pardillo, Circe</au><au>Morera-Díaz, Yanelys</au><au>Mazorra-Herrera, Zaima</au><au>Garcia-Rivera, Dagmar</au><au>Nodarse-Cuní, Hugo</au><au>Hernández-Bernal, Francisco</au><au>Muzio-Gonzalez, Verena</au><au>Aguilera-Barreto, Ana</au><au>Vazquez-Blomquist, Dania</au><au>Domínguez-Horta, Maria Del Carmen</au><au>Guillen-Nieto, Gerardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba</atitle><jtitle>Journal of interferon & cytokine research</jtitle><addtitle>J Interferon Cytokine Res</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>43</volume><issue>12</issue><spage>571</spage><epage>580</epage><pages>571-580</pages><issn>1079-9907</issn><issn>1557-7465</issn><eissn>1557-7465</eissn><abstract>The convergence of life sciences with neurosciences, nanotechnology, data management, and engineering has caused a technological diversification of the biotechnology, pharmaceutical, and medical technology industries, including the phenomenon of digital transformation, which has given rise to the so-called Fourth Industrial Revolution (Industry 4.0). Confronting the COVID-19 pandemic revealed the outstanding response capacity of the scientific community and the biopharmaceutical industry, based on a multidisciplinary and interinstitutional approach that has achieved an unprecedented integration in the history of biomedical science. Cuba, a small country, with scarce material resources, has had remarkable success in controlling the disease, which also highlights the impact of social factors. This report presents a summary of the most relevant presentations of selected topics during the scientific meeting, “BioHabana 2022: Cancer Immunotherapy and the COVID-19 Pandemic,” which was held in Havana Cuba in April 2022.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc., publishers</pub><pmid>38048299</pmid><doi>10.1089/jir.2023.0141</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-5011-2850</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1079-9907 |
| ispartof | Journal of interferon & cytokine research, 2023-12, Vol.43 (12), p.571-580 |
| issn | 1079-9907 1557-7465 1557-7465 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2898312293 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | COVID-19 Cuba Humans Immunotherapy Meeting Report Neoplasms - prevention & control Pandemics - prevention & control |
| title | BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A40%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BioHabana%202022:%20Preventive%20and%20Immunotherapeutic%20Strategies%20Against%20COVID-19%20and%20Cancer%20in%20Cuba&rft.jtitle=Journal%20of%20interferon%20&%20cytokine%20research&rft.au=Bello-Rivero,%20Iraldo&rft.date=2023-12-01&rft.volume=43&rft.issue=12&rft.spage=571&rft.epage=580&rft.pages=571-580&rft.issn=1079-9907&rft.eissn=1557-7465&rft_id=info:doi/10.1089/jir.2023.0141&rft_dat=%3Cproquest_cross%3E2898312293%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2898312293&rft_id=info:pmid/38048299&rfr_iscdi=true |